Valuation: Iqvia Holdings Inc.

Capitalization 25.93B 22.81B 21.4B 19.52B 35.96B 2,213B 40.62B 250B 97.53B 992B 97.26B 95.24B 3,689B P/E ratio 2025 *
19.2x
P/E ratio 2026 * 16.2x
Enterprise value 37.89B 33.33B 31.27B 28.52B 52.55B 3,234B 59.35B 365B 143B 1,450B 142B 139B 5,390B EV / Sales 2025 *
2.39x
EV / Sales 2026 * 2.2x
Free-Float
67.55%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Iqvia Holdings Inc.

1 day+2.40%
1 week-2.56%
Current month-16.59%
1 month-20.89%
3 months-28.50%
6 months-36.39%
Current year-25.16%
More quotes
1 week 137.49
Extreme 137.49
154.17
1 month 135.97
Extreme 135.97
188.38
Current year 135.97
Extreme 135.97
220
1 year 135.97
Extreme 135.97
252.88
3 years 135.97
Extreme 135.97
261.73
5 years 122.22
Extreme 122.22
285.61
10 years 55.01
Extreme 55.011
285.61
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 02/10/2016
Director of Finance/CFO 64 31/07/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 67 04/02/2015
Director/Board Member 59 31/12/2007
Chairman 64 02/10/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.40%-2.56%-36.43%-37.73% 25.93B
+2.33%+5.68%+10.89%-10.68% 48.1B
0.00%-2.30%-4.41%+7.76% 23.99B
+4.63%-2.47%-51.96%-41.56% 11.56B
+12.02%+11.14%-8.29%-38.44% 11.45B
+3.11%-0.97%-74.59%-81.63% 10.26B
-0.62%+1.70%+11.29%+49.12% 9.51B
-0.05%0.00%-0.18%-13.69% 9.15B
+2.93%-4.83%-22.78%+89.47% 8.35B
+2.20%-4.52%-20.13%-51.31% 7.93B
Average +2.89%+1.63%-19.66%-12.87% 16.62B
Weighted average by Cap. +2.60%+1.72%-13.43%-14.33%
See all sector performances

Financials

2025 *2026 *
Net sales 15.87B 13.97B 13.1B 11.95B 22.02B 1,355B 24.87B 153B 59.71B 608B 59.55B 58.31B 2,259B 16.8B 14.78B 13.87B 12.65B 23.31B 1,434B 26.32B 162B 63.21B 643B 63.03B 61.72B 2,391B
Net income 1.43B 1.25B 1.18B 1.07B 1.98B 122B 2.23B 13.73B 5.36B 54.57B 5.35B 5.24B 203B 1.64B 1.44B 1.35B 1.23B 2.27B 140B 2.57B 15.77B 6.16B 62.69B 6.14B 6.02B 233B
Net Debt 11.96B 10.52B 9.87B 9B 16.58B 1,021B 18.73B 115B 44.98B 458B 44.85B 43.92B 1,701B 11.08B 9.75B 9.14B 8.34B 15.37B 946B 17.36B 107B 41.68B 424B 41.56B 40.7B 1,576B
More financial data * Estimated data
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).
Employees
88,000
More about the company
Date Price Change Volume
23/04/25 147.06 $ +2.40% 2,294,958
22/04/25 143.61 $ +1.69% 1,734,183
21/04/25 141.22 $ -1.87% 1,967,486
17/04/25 143.91 $ -3.05% 3,302,598
16/04/25 148.44 $ -0.48% 1,322,238

Delayed Quote Nyse, April 23, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
147.06USD
Average target price
221.31USD
Spread / Average Target
+50.49%
Consensus

Quarterly revenue - Rate of surprise